Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Dupilumab users have a higher risk of developing alopecia areata.

Dupilumab may worsen hair loss in patients with alopecia areata.

Dupilumab may cause hair loss, so patients should be monitored.

γδ T cells are essential for wound healing after poxvirus infection.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Yangyin Qingre Huoxue Prescription may help treat atherosclerosis with fewer liver side effects than simvastatin.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.